IL1B and chronic myelogenous leukemia, BCR-ABL1 positive: Accordingly, IL-1β has been identified as a key cytokine in inflammation-related myeloid malignancies, including acute myeloid leukemia (AML) and chronic (CML) myeloid leukemia, as it supports cellular expansion and hence disease progression [14,15].